UWM
HUMA icon

Urban Wealth Management’s Humacyte HUMA Stock Holding History

Urban Wealth Management’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		$0 Buy
+11
New +$61 ﹤0.01% 353

Other funds holding HUMA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
YCMGA
York Capital Management Global Advisors New York $87.8M AUM 45.55% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PGP
Prescott General Partners Boca Raton, Florida $1.37B AUM 23.81% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Urban Wealth Management's HUMA Position: Q2 2022 in Review

Urban Wealth Management opened a new position in Humacyte (HUMA) in Q2 2022: 11 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #353 among its holdings.

78 funds tracked by Wall St. Rank hold HUMA as of Q2 2022.

  • Urban Wealth Management held 11 shares of Humacyte worth $0 as of Q2 2022.
  • Humacyte was a new Urban Wealth Management position in Q2 2022.
  • Humacyte made up ﹤0.01% of Urban Wealth Management's portfolio in Q2 2022, its #353 holding.
  • 78 funds tracked by Wall St. Rank held Humacyte as of Q2 2022.

Based on Urban Wealth Management's 13F filing for Q2 2022, filed 22 Jul 2022.